The study found that using the drug increased the risk of vomiting and nausea by more than four times and constipation and diarrhea by more than double
[8] It was found that acarbose reduced the incidence of diabetes mellitus type 2 when compared to placebo, however there was no conclusive evidence that acarbose, when compared to diet and exercise, metformin, placebo, or no intervention, improved all-cause mortality, reduced or increased risk of cardiovascular mortality, serious or non-serious adverse events, non-fatal stroke, congestive heart failure, or non-fatal myocardial infarction
Check Our Offers Table of Contents: Why is GLP-1 therapy popular for medical weight loss
It does this by breaking bonds between sugar and protein molecules
Its benefits are likely slow and require another agent working alongside for weight loss, and the athletic benefit is not conclusively proven